APA (7th ed.) Citation

Schwarting, S. K., Poledniczek, M., Metodiev, Y., Stolz, L., Hofmann, E. C. M., Hegenbart, U., . . . Siepen, F. a. d. (2024). RV-PA uncoupling is associated with increased mortality in transthyretin amyloid cardiomyopathy treated with tafamidis. Clinical research in cardiology. https://doi.org/10.1007/s00392-024-02576-2

Chicago Style (17th ed.) Citation

Schwarting, Stéphanie K., et al. "RV-PA Uncoupling Is Associated with Increased Mortality in Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis." Clinical Research in Cardiology 2024. https://doi.org/10.1007/s00392-024-02576-2.

MLA (9th ed.) Citation

Schwarting, Stéphanie K., et al. "RV-PA Uncoupling Is Associated with Increased Mortality in Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis." Clinical Research in Cardiology, 2024, https://doi.org/10.1007/s00392-024-02576-2.